Moximed

Moximed is a medical device company based in Fremont, California, founded in 2008. The company focuses on improving care for individuals with mild to moderate medial compartment knee osteoarthritis (OA). Moximed aims to help patients maintain active lifestyles by offering innovative treatment options that can delay or potentially avoid knee joint replacement. The flagship product, the MISHA™ Knee System, is the first implantable shock absorber designed specifically for medial compartment knee OA. This device reduces pain and improves function by unloading the knee joint with each step. It is intended for patients who have not found relief from conservative treatments and are either ineligible for or prefer to avoid joint replacement surgery. Moximed supports surgeons through education and training to ensure effective implantation and positive patient outcomes. Since its commercial launch in the United States in April 2023, the company has garnered interest from both academic and private practice surgeons, as well as patients seeking solutions for knee OA. Moximed has raised over $150 million to support its mission and expand access to the MISHA Knee System.

• Employees 71
• Founded 2006
• Annual Revenue $8100000
• Total Funding $259837656